Universidad de Granada Digibug
 

Repositorio Institucional de la Universidad de Granada >
1.-Investigación >
Departamentos, Grupos de Investigación e Institutos >
Departamento de Bioquímica y Biología Molecular II >
DBBM2 - Artículos >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10481/29690

Title: Identification of novel predictor classifiers for inflammatory bowel disease by gene expression profiling
Authors: Montero Meléndez, Trinidad
Llor, Xavier
García-Planella, Esther
Perretti, Mauro
Suárez García, Antonio
Issue Date: 2013
Abstract: Background: Improvement of patient quality of life is the ultimate goal of biomedical research, particularly when dealing with complex, chronic and debilitating conditions such as inflammatory bowel disease (IBD). This is largely dependent on receiving an accurate and rapid diagnose, an effective treatment and in the prediction and prevention of side effects and complications. The low sensitivity and specificity of current markers burden their general use in the clinical practice. New biomarkers with accurate predictive ability are needed to achieve a personalized approach that take the inter-individual differences into consideration.
Methods: We performed a high throughput approach using microarray gene expression profiling of colon pinch biopsies from IBD patients to identify predictive transcriptional signatures associated with intestinal inflammation, differential diagnosis (Crohn’s disease or ulcerative colitis), response to glucocorticoids (resistance and dependence) or prognosis (need for surgery). Class prediction was performed with self-validating Prophet software package.
Results: Transcriptional profiling divided patients in two subgroups that associated with degree of inflammation. Class predictors were identified with predictive accuracy ranging from 67 to 100%. The expression accuracy was confirmed by real time-PCR quantification. Functional analysis of the predictor genes showed that they play a role in immune responses to bacteria (PTN, OLFM4 and LILRA2), autophagy and endocytocis processes (ATG16L1, DNAJC6, VPS26B, RABGEF1, ITSN1 and TMEM127) and glucocorticoid receptor degradation (STS and MMD2).
Conclusions: We conclude that using analytical algorithms for class prediction discovery can be useful to uncover gene expression profiles and identify classifier genes with potential stratification utility of IBD patients, a major step towards personalized therapy.
Sponsorship: This study was funded by Fundació la Marató de TV3 (031531) and Spanish Health Ministry – Carlos III Institute (PI61550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Publisher: Public Library of Science (PLOS)
Keywords: Biomarkers
Biopsy
Diagnostic medicine
Gene expression
Inflammation
Inflammatory bowel diseases
Prognosis
URI: http://hdl.handle.net/10481/29690
ISSN: 1932-6203
Rights : Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License
Citation: Montero-Meléndez, T.; et al. Identification of novel predictor classifiers for inflammatory bowel disease by gene expression profiling. Plos One, 8(10): e76235 (2013). [http://hdl.handle.net/10481/29690]
Appears in Collections:DBBM2 - Artículos

Files in This Item:

File Description SizeFormat
MonteroMelendez_Inflammatory.pdf2.33 MBAdobe PDFView/Open
Recommend this item

This item is licensed under a Creative Commons License
Creative Commons

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! OpenAire compliant DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard - Feedback

© Universidad de Granada